|
ARF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.556430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.625020E-01 |
| Normal-vs-Stage2 |
1.472980E-01 |
| Normal-vs-Stage3 |
3.823700E-02 |
| Normal-vs-Stage4 |
4.281600E-02 |
| Stage1-vs-Stage2 |
3.644600E-03 |
| Stage1-vs-Stage3 |
3.211600E-01 |
| Stage1-vs-Stage4 |
3.225200E-01 |
| Stage2-vs-Stage3 |
1.584740E-03 |
| Stage2-vs-Stage4 |
1.503970E-03 |
| Stage3-vs-Stage4 |
8.520200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.841660E-02 |
| Normal-vs-AfricanAmerican |
1.563580E-01 |
| Normal-vs-Asian |
1.661230E-01 |
| Caucasian-vs-AfricanAmerican |
9.569000E-01 |
| Caucasian-vs-Asian |
6.808800E-01 |
| AfricanAmerican-vs-Asian |
8.091400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.293600E-01 |
| Normal-vs-Female |
1.161790E-01 |
| Male-vs-Female |
4.316400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.582000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.015200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.175800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.151840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.083450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.248000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.282000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.758800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.577600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.085200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.695400E-03 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
4.518200E-02 |
| Classical-VS-Normal |
1.875930E-03 |
| Tall-VS-Follicular |
1.55359947129341E-10 |
| Tall-VS-Other |
7.338700E-03 |
| Tall-VS-Normal |
2.00489999999665E-05 |
| Follicular-VS-Other |
1.850450E-01 |
| Follicular-VS-Normal |
3.78629999997493E-06 |
| Other-VS-Normal |
4.691200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.273400E-01 |
| Normal-vs-N1 |
1.022770E-01 |
| N0-vs-N1 |
1.607650E-02 |
|
|
